Beck Capital Management LLC Boosts Stake in Tenet Healthcare Corporation $THC

Beck Capital Management LLC increased its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 52.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 20,406 shares of the company’s stock after purchasing an additional 7,032 shares during the period. Beck Capital Management LLC’s holdings in Tenet Healthcare were worth $4,055,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of THC. Triumph Capital Management acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the fourth quarter valued at approximately $29,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at approximately $35,000. Finally, Meeder Asset Management Inc. boosted its stake in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Trading Up 0.9%

Shares of NYSE:THC opened at $174.67 on Friday. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21. The company’s 50 day moving average is $183.94 and its two-hundred day moving average is $199.94. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a market cap of $15.05 billion, a PE ratio of 9.08, a P/E/G ratio of 1.43 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the prior year, the business earned $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts predict that Tenet Healthcare Corporation will post 17.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on THC. KeyCorp reduced their target price on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Royal Bank Of Canada reduced their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Robert W. Baird cut their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Finally, Guggenheim cut their price objective on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a report on Friday, May 1st. Eighteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $244.16.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.